Abstracts

US PATIENT PREFERENCES FOR LONG-ACTING HIV TREATMENT: A DISCRETE CHOICE EXPERIMENT

Background: Recent advances in long-acting antiretroviral therapy (LA-ART) could provide new options for HIV treatment and reduce adherence barriers, if regimens are acceptable to patients. We elicited preferences for key attributes of potential LA-ART regimens among people with HIV (PWH) in the United States, focusing on four different treatment modalities (oral tablets, subcutaneous and intramuscular…

PHASE 1 CLINICAL TRIALS OF A Q-GRIFFITHSIN NASAL SPRAY FOR SARS-CoV-2 PROPHYLAXIS

Background: The currently approved vaccines do not induce sterilizing immunity against SAR-CoV-2 infection, and immunity wanes over time. A robust broad spectrum topical prophylaxis strategy could protect vulnerable populations in the face of continuous evolution of SARS-CoV-2. The algal antiviral lectin Griffithsin (GRFT), and an engineered oxidation-resistant variant Q-GRFT have robust entry inhibitory activity against…

NO EVIDENCE OF PERTURBATIONS OF THE BREAST MILK MICROBIOME BY ANTIRETROVIRAL THERAPY

Background: Antiretroviral treatment (ART) has greatly reduced AIDS-related morbidity and mortality in women living with HIV (LWH) and has broken the chain of mother-to-child transmission (MTCT) of HIV-1 both peripartum and through breastfeeding. Breastfeeding has profound benefits including reducing infant mortality. Human milk contains over 200 beneficial factors including cells, antibodies, human milk oligosaccharides and…

HARD-TO-TREAT PHENOTYPES INCREASE TIME TO CULTURE CONVERSION IN DRUG-RESISTANT TB

Background: Safer, better, and shorter treatment for highly resistant tuberculosis (TB) is an urgent global health need. The phase 3 Nix-TB (NCT02333799) clinical trial developed a six-month treatment consisting of high-dose linezolid, bedaquiline and pretomanid (BPaL) for MDR and XDR-TB. Here, we investigate the relationship between patient characteristics and efficacy endpoints collected in the Nix-TB…

NEUROCOGNITIVE FUNCTION AMONG SCHOOL-AGED CHILDREN AFFECTED BY HIV IN BOTSWANA

Background: Children living with HIV (HIV+) have higher rates of cognitive dysfunction, particularly in domains of attention, information processing speed, episodic memory, psychomotor, and executive functioning. HIV-exposed uninfected children (HEU) have been shown in some, but not all, studies to suffer from more neurodevelopmental delays than HIV-unexposed uninfected children (HUU). The Penn Computerized Neurocognitive Battery…

TARGETING THE HOST-VIRUS INTERFACE TO BLOCK SARS-CoV-2 ASSEMBLY IN AIRWAY CELLS

Background: The rapid emergence of the SARS-CoV-2 Omicron variant that evades many therapies illustrates the need for antiviral treatments with high genetic barriers to resistance. The small molecule PAV-104, identified through a moderate-throughput screen involving cell-free protein synthesis, was recently shown to target a subset of host protein assembly machinery in a manner specific to…